• KOL
  • Disease
  • Polycystic
  • Polycystic Ovary
  • Polycystic Ovary Syndrome
  • Richard S Legro
  •  

    Prominent publications by Richard S Legro

    KOL Index score: 26172

    STUDY QUESTION: What is the recommended assessment and management of women with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise and consumer preference?

    SUMMARY ANSWER: International evidence-based guidelines, including 166 recommendations and practice points, addressed prioritized questions to promote consistent, evidence-based care and improve the experience and health outcomes of women with PCOS.

    WHAT IS KNOWN ALREADY: Previous guidelines ...

    Also Ranks for: Based Guideline |  international evidence |  management pcos |  recommendations assessment |  polycystic ovary
    KOL Index score: 20822

    Polycystic ovary syndrome (PCOS) is recognized as the most common endocrine disorder of reproductive-aged women around the world. This document, produced by the collaboration of the American Association of Clinical Endocrinologists and the Androgen Excess Society aims to highlight the most important clinical issues confronting physicians and their patients with PCOS. It is a summary of current best practices in 2014. Insulin resistance is believed to play an intrinsic role in the ...

    Also Ranks for: Women Pcos |  insulin resistance |  polycystic ovary syndrome |  weight loss |  gestational diabetes
    KOL Index score: 19745

    Racial origin and family history of type 2 diabetes impact upon the risk of developing impaired glucose tolerance (IGT) and type 2 diabetes, both of which are common in women with polycystic ovary syndrome (PCOS). We examined the effects of race and family history of type 2 diabetes on the risk of IGT and type 2 diabetes in a large cohort of women with PCOS. Data obtained at baseline were analyzed from 408 premenopausal women with PCOS. Multivariate linear regression models were used to ...

    Also Ranks for: 2 Diabetes |  pcos igt |  polycystic ovary syndrome |  glucose insulin |  women type
    KOL Index score: 19673

    CONTEXT: Adult women with polycystic ovary syndrome (PCOS) have an increased prevalence of the metabolic syndrome (MBS). The prevalence of MBS is also increasing in adolescents.

    OBJECTIVE: Our objective was to test the hypothesis that the prevalence of MBS is increased in adolescent girls with PCOS compared with the general population and to determine the factors associated with an increased risk of the MBS in PCOS.

    DESIGN AND SETTING: We conducted a cross-sectional case-control study at ...

    Also Ranks for: Adolescent Girls |  insulin resistance |  mbs pcos |  metabolic syndrome |  polycystic ovary
    KOL Index score: 19515

    STUDY QUESTION: Do oral contraceptives (OCs) and progestins impact live birth rate of IVF when used for cycle scheduling in women with polycystic ovary syndrome (PCOS)?

    SUMMARY ANSWER: OCs used for scheduling IVF cycle were associated with lowered rates of pregnancy and live birth after fresh embryo transfer, whereas progestins used for this purpose yield higher rates of pregnancy and live birth than OCs.

    WHAT IS KNOWN ALREADY: Due to oligo-menorrhea in PCOS, OCs and progestin are ...

    Also Ranks for: Oral Contraceptives |  polycystic ovary syndrome |  women pcos |  live birth |  ivf outcomes
    KOL Index score: 19214

    STUDY QUESTION: Can a core outcome set to standardize outcome selection, collection and reporting across future infertility research be developed?

    SUMMARY ANSWER: A minimum data set, known as a core outcome set, has been developed for randomized controlled trials (RCTs) and systematic reviews evaluating potential treatments for infertility.

    WHAT IS KNOWN ALREADY: Complex issues, including a failure to consider the perspectives of people with fertility problems when selecting outcomes, ...

    Also Ranks for: Core Outcome |  future infertility |  sponsorship ferring |  consultancy fees |  consensus development
    KOL Index score: 18300

    Polycystic Ovary Syndrome (PCOS) is recognized as the most common endocrine disorder of reproductive-aged women around the world. This document, produced by the collaboration of the American Association of Clinical Endocrinologists (AACE) and the Androgen Excess and PCOS Society (AES) aims to highlight the most important clinical issues confronting physicians and their patients with PCOS. It is a summary of current best practices in 2015. PCOS has been defined using various criteria, ...

    Also Ranks for: Androgen Excess |  diagnosis pcos |  polycystic ovary |  menstrual irregularities |  ovulatory dysfunction
    KOL Index score: 17625

    STUDY QUESTION: Can the priorities for future research in infertility be identified?

    SUMMARY ANSWER: The top 10 research priorities for the four areas of male infertility, female and unexplained infertility, medically assisted reproduction and ethics, access and organization of care for people with fertility problems were identified.

    WHAT IS KNOWN ALREADY: Many fundamental questions regarding the prevention, management and consequences of infertility remain unanswered. This is a barrier ...

    Also Ranks for: Future Infertility |  sponsorship ferring |  international consensus |  consultancy fees |  development study
    KOL Index score: 16918

    STUDY QUESTION: Does fertility-related quality of life (FertiQOL) differ by infertility diagnosis between women with polycystic ovary syndrome (PCOS) and their partners, compared with couples with unexplained infertility (UI)?

    SUMMARY ANSWER: Women with PCOS report lower QOL than those with UI, whereas males with UI report lower QOL than males with PCOS partners.

    WHAT IS KNOWN ALREADY: The fertility-specific QOL survey, FertiQOL, has been used to examine fertility-related QOL in a number ...

    Also Ranks for: Polycystic Ovary Syndrome |  women pcos |  unexplained infertility |  fertiqol scores |  male partners
    KOL Index score: 16389

    BACKGROUND: The Centers for Disease Control and Prevention's US Medical Eligibility Criteria for Contraceptive Use recommends that combined hormonal contraceptives (ie, birth control pills, contraceptive patch, vaginal ring) should be avoided in women with specific medical conditions because of the increased risk of cardiovascular events associated with estrogen use. Whether women with category 3 (theoretical or proven risk usually outweigh the advantages) or category 4 (unacceptable ...

    Also Ranks for: Hormonal Contraception |  medical contraindications |  estrogen contraceptive |  venous thromboembolism |  reproductiveage women
    KOL Index score: 16294

    BACKGROUND: The transfer of fresh embryos is generally preferred over the transfer of frozen embryos for in vitro fertilization (IVF), but some evidence suggests that frozen-embryo transfer may improve the live-birth rate and lower the rates of the ovarian hyperstimulation syndrome and pregnancy complications in women with the polycystic ovary syndrome.

    METHODS: In this multicenter trial, we randomly assigned 1508 infertile women with the polycystic ovary syndrome who were undergoing ...

    Also Ranks for: Frozen Embryos |  polycystic ovary syndrome |  transfer embryo |  rate ratio |  live birth
    KOL Index score: 16008

    BACKGROUND: Here we describe the consensus guideline methodology, summarise the evidence-based recommendations we provided to the World Health Organisation (WHO) for their consideration in the development of global guidance and present a narrative review on the management of anovulatory infertility in women with polycystic ovary syndrome (PCOS).

    OBJECTIVE AND RATIONALE: The aim of this paper was to present an evidence base for the management of anovulatory PCOS.

    SEARCH METHODS: The ...

    Also Ranks for: Anovulatory Infertility |  pcos women |  ovulation induction |  polycystic ovary |  female fertilization
    KOL Index score: 15984

    CONTEXT: A previous genome-wide association study in Chinese women with polycystic ovary syndrome (PCOS) identified a region on chromosome 2p16.3 encoding the LH/choriogonadotropin receptor (LHCGR) and FSH receptor (FSHR) genes as a reproducible PCOS susceptibility locus.

    OBJECTIVE: The objective of the study was to determine the role of the LHCGR and/or FSHR gene in the etiology of PCOS in women of European ancestry.

    DESIGN: This was a genetic association study in a European ancestry ...

    Also Ranks for: European Ancestry |  women pcos |  polycystic ovary |  fsh receptors |  evidence association
    KOL Index score: 15786

    Importance: Acupuncture is used to induce ovulation in some women with polycystic ovary syndrome, without supporting clinical evidence.

    Objective: To assess whether active acupuncture, either alone or combined with clomiphene, increases the likelihood of live births among women with polycystic ovary syndrome.

    Design, Setting, and Participants: A double-blind (clomiphene vs placebo), single-blind (active vs control acupuncture) factorial trial was conducted at 21 sites (27 hospitals) in ...

    Also Ranks for: Chinese Women |  polycystic ovary |  active acupuncture |  live births |  randomized clinical trial

     

    Richard S Legro: Influence Statistics

    Sample of concepts for which Richard S Legro is among the top experts in the world.
    Concept World rank
    disturbances obesity #1
    syndrome frozen #1
    adult male relatives #1
    pcos quantitative traits #1
    obg nwg #1
    pcos sisters women #1
    nih nichd #1
    aspects endocrine syndrome #1
    hyperandrogenemia insulin #1
    difference total cholesterol #1
    women patient dropouts #1
    aor oligo #1
    cohorts bsa #1
    association t2d locus #1
    pcos ovulation induction #1
    bsa reduced amh #1
    pcos female relatives #1
    pcos subtypes #1
    data sharing requirements #1
    primary clinical endpoints #1
    new millenium understanding #1
    pcos a8 pcos #1
    common treatments pcos #1
    iu 17 ± #1
    measures circulating androgens #1
    metabolic phenotype women #1
    fsh receptors human #1
    endocrine abnormalities syndrome #1
    spontaneous menses ocs #1
    pcos white controls #1
    p531×10 #1
    aor eumenorrhea #1
    “metabolic” #1
    pcos regional differences #1
    t2d locus proinsulin #1
    pcos hyperandrogenemia #1
    pcos including #1
    d19s884 association #1
    prevalence fasting dysglycemia #1
    symptomoriented treatments #1
    insulin resistance tgz #1
    common variants dennd1a #1
    surgery reproductive #1
    variants dennd1a #1
    preeclampsia transfer #1
    pcos daughters levels #1
    preconception intervention #1
    oligo risk #1
    control mothers pcos #1
    excon ed3 #1

    Key People For Polycystic Ovary Syndrome

    Top KOLs in the world
    #1
    Richard S Legro
    polycystic ovary syndrome insulin resistance women pcos
    #2
    Ricardo Azziz
    polycystic ovary syndrome women pcos insulin resistance
    #3
    Andrea Elizabeth Dunaif
    polycystic ovary syndrome insulin resistance women pcos
    #4
    Robert John Norman
    polycystic ovary syndrome weight loss women pcos
    #5
    Stephen FRANKS
    polycystic ovary syndrome granulosa cells women pcos
    #6
    Evanthia Diamanti‐Kandarakis
    polycystic ovary syndrome insulin resistance women pcos

    Richard S Legro:Expert Impact

    Concepts for whichRichard S Legrohas direct influence:Polycystic ovary syndrome,  Polycystic ovary,  Ovary syndrome,  Insulin resistance,  Women pcos,  Unexplained infertility,  Live birth,  Metabolic syndrome.

    Richard S Legro:KOL impact

    Concepts related to the work of other authors for whichfor which Richard S Legro has influence:Polycystic ovary syndrome,  Insulin resistance,  Women pcos,  Weight loss,  Ovulation induction,  Type 2 diabetes,  Bariatric surgery.


     

    Tools

    Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


    Department of Obstetrics and Gynecology, Penn State College of Medicine, Hershey, Pennsylvania. | Department of Obstetrics & Gynecology, Penn State Health, Milton S Hershey Medical Center, Penn State College of Medicine, Hershey, PA 17033, USA | Depa